Total Funding
94
56
Total FundingPost-IPO Equity raised
Growth Score
-3 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3720
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Kathy Ivey: Senior Director Gene Therapy Biology- Whit Tingley: Chief Medical Officer
About the Company
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease. The company's therapies address heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration,
enabling physicians to regenerate heart tissue, and additional programs focused on cardiomyopathies.
